key: cord-0956994-qmfxnhoa
authors: van de Venis, Lotte; van de Warrenburg, Bart P. C.; Weerdesteyn, Vivian; van Lith, Bas J. H.; Geurts, Alexander C. H.; Nonnekes, Jorik
title: COVID-19 reveals influence of physical activity on symptom severity in hereditary spastic paraplegia
date: 2020-07-07
journal: J Neurol
DOI: 10.1007/s00415-020-10016-0
sha: 4d8d850ce7778a70cb01aef4096e91f8f4edff1f
doc_id: 956994
cord_uid: qmfxnhoa

nan

Hereditary spastic paraplegia (HSP) is a neurodegenerative disorder, characterized by progressive spasticity and muscle weakness of both lower extremities [1] . Spasticity-related symptoms such as muscle stiffness and gait impairments are common and disabling in HSP [2] . Moreover, patients experience a substantial burden from both physical and mental fatigue [2] . Our clinical experience is that physical activity positively impacts on these symptoms, whereas psychological stress may impact negatively. This has, however, not been formally investigated. The (partial) lockdown due to the COVID-19 pandemic has profoundly changed people's normal routine, assumably reducing levels of physical activity and increasing psychological stress [3] , thereby creating an opportunity to explore the influence of these changes on symptom severity in HSP.

We conducted a web-based survey among people with pure HSP [2] in the Netherlands. An invitation was sent to participants from our previous survey (n = 109), which was approved by our regional medical-ethics committee. Participants were asked to rate possible changes in levels of physical activity, psychological stress, and symptom severity on a 5-point Likert scale. They were invited and completed the questionnaire during the fifth week of the partial lockdown in the Netherlands. Descriptive statistics were used to analyze the primary data. Additionally, chi-square tests (or Fisher-exact-tests if appropriate) were used to test whether changes in physical activity and psychological stress were associated with changes in symptom severity (p < 0.05). When both physical activity and psychological stress were associated with a specific change in symptom severity, multivariate logistic forward regression analysis was applied to correct for collinearity of these independent determinants.

Fifty-eight participants returned a completed survey. Their average age was 57 years (range 30-77) and 47% was male. A reduction of physical activities was reported by 74% (33% strong decrease, 41% mild decrease), whereas 19% reported no change and 7% mild increase. An increase in psychological stress was reported by 43% (3% strong increase, 40% mild increase), 50% reported no change, and 7% decrease (2% strong, 5% mild). The majority reported a general increase in symptom severity (Fig. 1) .

Participants with reduced physical activity more often experienced increased muscle stiffness (p = 0.001), pain (p = 0.004), physical fatigue [χ 2 (1) = 4.680, p = 0.031], and gait impairments [χ 2 (1) = 5.129, p = 0.024] compared to those with no change or an increase in physical activity (Fig. 2) . The same trend was seen for balance impairments Six participants were treated with intramuscular botulinum toxin injections to reduce spasticity-related symptoms. During the lockdown, treatment continued in five participants. The partial lockdown in the Netherlands due to the COVID-19 pandemic resulted in a reduction of physical activity in the majority of participants with HSP, which proved to be associated with increased muscle stiffness, pain, physical fatigue and gait impairments. This result is coherent with findings in other chronic (neurodegenerative) conditions [4] and underscores the potential impact of physical activity on symptom severity in people with HSP. Future studies may investigate whether the present findings can be extended to other conditions resulting in spastic paraparesis (e.g. multiple sclerosis and primary lateral sclerosis). Future studies may also evaluate the effect of interventions targeting daily physical activity in this population, preferably including objective outcomes, which were lacking in the present study. Another limitation is the lack of comparison between current and previous clinical status, which was not possible due to the lockdown restrictions. An additional limitation is the risk of selection bias, which may have resulted in an overestimation of changes in physical activity, psychological stress, and/or symptom severity. The question remains whether people with HSP are able to return to 'baseline' levels of functioning after release of the lockdown and expected increase in physical activity. 

Hereditary spastic paraplegia: from diagnosis to emerging therapeutic approaches

Experienced complaints, activity limitations and loss of motor capacities in patients with pure hereditary spastic paraplegia: a web-based survey in the Netherlands

The impact of the COVID-19 pandemic on Parkinson's disease: hidden sorrows and emerging opportunities

Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson's disease: a double-blind, randomised controlled trial

Author contributions LV, JN: collecting survey data, interpreting survey data, and drafting the manuscript. BL, BW, VW, AG: critical revision of manuscript.Funding This study was supported by the Jacques and Gloria Gossweiler Foundation.